VERACYTE, INC. Excess Tax Benefit from Share-based Compensation, Operating Activities
VERACYTE, INC. (VCYT) reported Excess Tax Benefit from Share-based Compensation, Operating Activities of $300.00 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-20.
Discontinued › Notes › Compensation Related Costs
us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities · last filed 2014-03-20
- VERACYTE, INC. excess tax benefit from share-based compensation, operating activities for fiscal 2013 was $300.00K.
| Period end | Excess Tax Benefit from Share-based Compensation, Operating Activities 12 month |
|---|---|
| 2013-12-31 | $300.00K 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |